Global Health Economics & Outcomes Research (HEOR) Director

readiness and post-launch updates and development of core HEOR/Access deliverables including systematic and targeted literature reviews, burden of illness studies, unmet medical needs, clinical and patient-relevant outcomes, clinical guidelines, comparative effectiveness including evidence synthesis (including indirect treatment comparisons and network meta-analyses), Cost-Effectiveness Analysis models, Budget Impact Analysis models, Global Value Dossiers, Payer/Product Value Propositions, Objection Handlers for Ipsen products.Lead EU HTA Regulation JCA planning and execution as applicable aligned with product assignments. Support Payer value evidence communication through presentation of abstract/posters of key work at clinical and HEOR conferences and manuscript publications.Contribute to development, updates and execution of cross-functional Integrated Evidence Generation Plans for Ipsen products working with cross-functional teams ensuring strategic alignment of planned and ongoing

Title:Global Health Economics & Outcomes Research (HEOR) DirectorCompany:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company's success. Join us on our journey towards sustainable growth, creating real impact on patients and society!For more information, visit us at and follow our latest news on, HEOR activities.Lead and inform RWE, health outcomes / Patient-reported outcomes strategy and execution supporting development of a compelling Value proposition for payers and other key stakeholders.Lead and inform pipeline target product and value profile and clinical development plans including payer-relevant endpoint in clinical trials.Support development of pricing policy and market access of the company products.Work collaboratively with local affiliates and global cross-functional team including but not limited to Global Medical A airs, Global Regulatory Affairs, Clinical, Biostatistics, Public Affairs, Marketing etc.Stay abreast of the evolving payer/HTA landscape in terms of policies, guidelines and trends leveraging up-to-date knowledge in strategic HEOR planning.Provide training to local country colleagues on value evidence for local adaptation and use.SKILLS & EDUCATIONA post graduate degree in health economics or related quantitative discipline.At least 8
years' relevant experience in the field of HEOR in pharma industry, consultancy, or Academia, in an international setting.Experience working on international HTA submissions.Strong scientific analysis, interpretative and writing skills.Knowledge of international health care systems.Expertise on HEOR from Oncology, Rare Disease and/or Neuroscience including evidence synthesis, cost-effectiveness and budget impact modeling, RWE methodologies for outcomes research and PROs.Knowledge of trial design and understanding of key clinical, PRO and resource utilization endpoints.#LI-HybridWe are committed to creating a workplace where everyone feels heard, valued, and supported; where we embrace "The Real Us". The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities. When we include diverse ways of thinking, we make more thoughtful decisions and discover more innovative solutions. Together we strive to better